HBsAg seroconversion with pegylated interferon treatment for chronic hepatitis BFeruze Yılmaz Enç, Canan YeşiloğluGöztepe Training and Research Hospital, Gastroenterology, Istanbul
Each year HBsAg seroconversion appears spontenously between the range of 1-2 percent and also antiHBs appears in 1/3 of these cases. HBsAg seroconversion is % 4 for the treatment with convensional interferon and this rate is also similar for the treatment with pegylated interferon. Here we present a patient with chronic hepatitis B who treated with pegylated interferon, had seroconversion of HBsAg. Keywords: Chronic hepatit B, treatment with peginterferon, anti HBs apperance
Kronik hepatit B’de peginterferon tedavisiFeruze Yılmaz Enç, Canan YeşiloğluGöztepe Eğitim Araştırma Hastanesi, Gastroenteroloji Kliniği, İstanbul
Anahtar Kelimeler: Kronik hepatit B, peginterferon tedavisi, anti HBs pozitifleşmesi
Feruze Yılmaz Enç, Canan Yeşiloğlu. HBsAg seroconversion with pegylated interferon treatment for chronic hepatitis B. Medeniyet Med J. 2007; 22(4): 156-157
Corresponding Author: Feruze Yılmaz Enç, Türkiye |
|